A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy |
Park, Hye-Li
(Department of Radiation Oncology, CHA Bundang Medical Center, CHA University)
Kim, Ja-Young (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) Lee, Bo-Mi (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) Chang, Sei-Kyung (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) Ko, Seung-Young (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) Kim, Sung-Jun (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) Park, Dong-Soo (Department of Urology, CHA Bundang Medical Center, CHA University) Shin, Hyun-Soo (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) |
1 | Parker ML, Damyanovich A, Haycocks T, Haider M, Bayley A, Catton CN. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intraprostatic fiducial markers for computed tomography coregistration. Radiother Oncol 2003;66:217-24. DOI ScienceOn |
2 | Prete JJ, Prestidge BR, Bice WS, Dubois DF, Hotchkiss LA. Comparison of MRI-and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Radiat Oncol Investig 1998;6:90-6. DOI ScienceOn |
3 | Langenhuijsen JF, van Lin EN, Hoffmann AL, et al. Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy. Urol Oncol 2011;29:52-7. DOI ScienceOn |
4 | Tanaka O, Hayashi S, Matsuo M, et al. MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol 2008;88:115-20. DOI ScienceOn |
5 | Smith WL, Lewis C, Bauman G, et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 2007;67:1238-47. DOI ScienceOn |
6 | Messing EM, Zhang JB, Rubens DJ, et al. Intraoperative optimized inverse planning for prostate brachytherapy: early experience. Int J Radiat Oncol Biol Phys 1999;44:801-8. DOI ScienceOn |
7 | Roach M 3rd, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for threedimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:1011-8. DOI ScienceOn |
8 | Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Defi nition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999;43:57-66. DOI ScienceOn |
9 | Kagawa K, Lee WR, Schultheiss TE, Hunt MA, Shaer AH, Hanks GE. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;38:319-25. DOI ScienceOn |
10 | Fogh S, Doyle L, Yu A, et al. A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation. Brachytherapy 2010;9:335-40. DOI ScienceOn |
11 | Dubois DF, Prestidge BR, Hotchkiss LA, Prete JJ, Bice WS Jr. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 1998;207:785-9. DOI |
12 | Chauveinc L, Flam T, Solignac S, et al. Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group. Int J Radiat Oncol Biol Phys 2004;59:691-5. DOI ScienceOn |
13 | Salembier C, Lavagnini P, Nickers P, et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 2007;83:3-10. DOI ScienceOn |
14 | Polo A, Salembier C, Venselaar J, Hoskin P; PROBATE group of the GEC ESTRO. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiother Oncol 2010;94:12-23. DOI ScienceOn |
15 | Stock RG, Cesaretti JA, Stone NN. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:810-6. DOI ScienceOn |
16 | Ishiyama H, Nakamura R, Satoh T, et al. Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy. Brachytherapy 2010;9:219-23. DOI ScienceOn |
17 | Hinnen KA, Battermann JJ, van Roermund JG, et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2010;76:1433-8. DOI ScienceOn |
18 | Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2000;47:1261-6. DOI ScienceOn |
19 | Prestidge BR, Prete JJ, Buchholz TA, et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 1998;40:461-5. DOI ScienceOn |
20 | Williams BV, Horton J, Lawyer A, Chapman J. Loading technique comparison in permanent 125I prostate implants. Med Dosim 1999;24:273-7. DOI ScienceOn |